The federal complaint, which was filed May 20, alleged the company made the following FDA violations between 2014 and 2021: failure to meet sterility minimums, labeling inadequacies, improper airflow, structural disrepair, record-keeping disparities and mold in cleanroom suites, according to the Justice Department.
Edge Pharma did not deny or confirm the allegations of supplying adulterated and misbranded prescriptions, but said it planned to settle the suit.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
